Cancer Biology & Medicine

Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition
Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers
Major roles of the circadian clock in cancer

Latest Articles

Open Access
Plasma L-aspartic acid predicts the risk of gastric cancer and modifies the primary prevention effect: a multistage metabolomic profiling and Mendelian randomization study
Mengyuan Wang, Zhouyi Yin, Hengmin Xu, Zongchao Liu, Sha Huang, Wenhui Wu, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li

Cancer Biology & Medicine April 2025, 20240523; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0523
Open Access
Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma
Tianshu Yu, Xianhuo Wang, Ou Bai, Huilai Zhang and Wenbin Qian

Cancer Biology & Medicine April 2025, 20240538; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0538
Open Access
Neoepitope BTLA^P267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
Fang Liu, Hua Chen, Suxin Wu, Chenlu Zhu, Mingji Zhang, Wei Rui, Dong Zhou, Yang Wang, Xin Lin, Xueqiang Zhao and Yunbin Ye

Cancer Biology & Medicine April 2025, 20240434; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0434
Open Access
MDM1 overexpression promotes p53 expression and cell apoptosis to enhance therapeutic sensitivity to chemoradiotherapy in patients with colorectal cancer
Ningxin Ren, Hongxia Chen, Ying Huang, Jing Jin, Shaosen Zhang, Ruoqing Yan, Mengjie Li, Linlin Zheng, Shuangmei Zou, Yexiong Li, Wen Tan and Dongxin Lin

Cancer Biology & Medicine March 2025, 22 (3) 266-283; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0540
Open Access
Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window
Kaibo Ding, Dujiang Liu, Xinyue Li, Zhongsheng Peng, Lin Zhu and Yanjun Xu

Cancer Biology & Medicine March 2025, 22 (3) 284-294; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0457
Open Access
Current status of multiple markers in precision immunotherapy for colorectal cancer
Chao Liu, Ya Lan, Hong Wang and Yanqiao Zhang

Cancer Biology & Medicine March 2025, 22 (3) 205-211; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0030

Cover Story